Anyone trying to refute the fact that CDEL holds a short position in excess of 16 million shares in CardioGenics is ignoring what is happening in the market. Since August 2015 CDEL has sold, on balance, close to 19 million shares. Approximately 2.3 million shares were sold by a convertible note holder in early August. Some posters have commented that the shares sold by CDEL could have been long shares. That scenerio is impossible......CardioGenics is aware that close to 90 percent of the shares publically held are held by individuals who have not sold any shares during this period and do not have accounts with CDEL. That leaves less then seven million shares that are available to be sold. It is difficult to believe that even 20 percent of these shares were sold through CDEL. The only possible conclusion is that CDEL is selling the shares short...Whether the shares were sold "naked" depends on Citadel's ability to borrow the stock. If the shares were placed in a account in one of the firms foreign subsideries the short position would not have to be reported to FINRA..